Andre Goy, MD, on responses & outcomes when treating lymphoma with CAR-T therapies

Dr. Goy, Chairman and Director of John Theurer Cancer Center, Chief of the Division of Lymphoma, Hackensack University Medical Center, provides opinion on the responses and outcomes when treating lymphoma with CAR-T therapies and whether they will become a significant part of the treatment regimens